Biopharmaceutical Development & Production Week consists of nine conferences on topics ranging from antibody development and production to outsourcing manufacturing of biopharmaceuticals. This event gives researchers a chance to learn from a variety of industry experts, hear about new technologies and products, access over 100 speakers, and network with professionals from different disciplines.
Staff scientists from Charles River Biopharmaceutical Services (BPS) and Preclinical Services (PCS) will be giving three presentations at two of the following conferences during the week-long meeting.
Viral Safety for Biologicals Conference
February 27-28, 2012
- “Overview of Regulations, Strategies and Methods Used to Minimize the Risk of Virus Contamination of Biopharmaceutical Processes and Products through Raw Materials”
Horst Ruppach, PhD
Tuesday, February 28th, 2012 at 11:15 AM
Biobetters & Biosimilars: Technologies and Development Strategies Conference
February 29 - March 2, 2012
- “Technical Challenges for the Quality Testing of Biosimilars and Biobetters”
Ulrike Herbrand and Simone Scotti
Friday, March 2nd, 2012 at 10:45 AM
- “Strategies for Development of Immuno- and Cell-Based Assays Supporting Preclinical and Clinical Biosimilar and Biobetter Programs”
Christina M. Satterwhite, PhD, and Kelly Colletti, PhD, MBA
Friday, March 2nd, 2012 at 11:15 AM
Charles River will also be exhibiting during Biopharmaceutical Development & Production Week. Stop by Booth #109, where professional staff from PCS and BPS will be discussing biosimilars and biobetters development and viral clearance studies, respectively. Click on the following links to learn more about Charles River Biopharmaceutical Services and Preclinical Services. We are proud to be a 2012 silver sponsor at this meeting.
For more information about our participation at these conferences, please contact us at events@crl.com.